Insider Transactions Reported by 18 Insiders of Ocugen, Inc.

Symbol: OCGN on Nasdaq
Location: Malvern, PA

Quick Takeaways

OCGN - Ocugen, Inc. has 18 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 07 May 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Ocugen, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Shankar Musunuri	Chief Executive Officer, Director	$7,931,589	Mixed	02 Jan 2026
Junge Zhang	Director	$1,835,076	Mixed	01 Apr 2026
Essalima Johnson Greene	Chief Financial Officer	$705,493	Mixed	04 Mar 2026
Arun Upadhyay	Chief Scientific Officer, Head of Research, Development and Medical	$273,893	Mixed	02 Jan 2025
Ramesh Ramachandran	Chief Accounting Officer	$271,830	Mixed	02 Jan 2026
Quan Anh Vu	Cfo/Cbo	$108,355	Mixed	06 Mar 2023
Jessica Crespo	CAO/SVP, Finance	$105,445	Mixed	03 Jan 2023
Sanjay Subramanian	Chief Financial Officer	$105,215	Mixed	03 Jan 2022
Kirsten Castillo	Director	$68,543	Filing P/S	05 Jun 2025
Manish Potti	Director	$47,470	Mixed	16 Dec 2021
Prabhavathi Fernandes	Director	$9,095	Filing P/S	26 Nov 2024
Huma Qamar	Chief Medical Officer	$1,073	Mixed	02 Jan 2025
Uday Kompella	Director		Mixed	05 Jun 2025
Satishchandran Chandrasekhar	Director		Mixed	05 Jun 2025
Michael Breininger	Title: Interim Chief Accounting Officer; Exhibit List: Exhibit 24.1 - Power of Attorney		Mixed	15 Sep 2023
Blaise Coleman	Director		Mixed	05 Jun 2025
Marna C. Whittington	Director		Mixed	28 Jun 2024
Ramesh Kumar	Director		Mixed	09 Jun 2023

Top shareholders of Ocugen, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MILLENNIUM MANAGEMENT LLC	13D/G 13F	Company	5.2%	17,074,584	$30,904,997	$0	09 Apr 2026	13D/G 13F
JANUS HENDERSON GROUP PLC	13D/G	—	6%	20,000,000	$26,800,000	$0	28 Nov 2025	13D/G
VANGUARD GROUP INC	13F	Company	5%	16,475,562	$22,242,009	—	31 Dec 2025	13F
Shankar Musunuri	3/4/5	Chief Executive Officer, Director	— mixed-class rows	9,224,424 mixed-class rows	$7,931,589	—	02 Jan 2026	3/4/5
UBS Group AG	13F	Company	1.5%	4,849,353	$6,546,627	—	31 Dec 2025	13F
BlackRock, Inc.	13F 13D/G	Company	1.9% from 13D/G	4,556,544	$6,151,334	—	31 Dec 2025	13F 13D/G
STATE STREET CORP	13F 13D/G	Company · STATE STREET CORPORATION	2% from 13D/G	3,978,738	$5,371,296	—	31 Dec 2025	13F 13D/G
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	3,819,242	$5,158,632	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	0.77%	2,530,956	$3,416,791	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.7%	2,302,475	$3,108,341	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.52%	1,700,400	$2,295,540	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.52%	1,692,134	$2,284,381	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.42%	1,385,953	$1,871,037	—	31 Dec 2025	13F
Junge Zhang	3/4/5	Director	— mixed-class rows	1,426,245 mixed-class rows	$1,835,076	—	01 Apr 2026	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.35%	1,150,460	$1,553,121	—	31 Dec 2025	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.31%	1,005,981	$1,358,074	—	31 Dec 2025	13F
Rinkey Investments	13F	Company	0.3%	991,186	$1,338,101	—	31 Dec 2025	13F
Corient Private Wealth LLC	13F	Company	0.27%	900,000	$1,215,000	—	31 Dec 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.27%	885,118	$1,195,000	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.21%	678,547	$916,038	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.2%	666,237	$899,420	—	31 Dec 2025	13F
Essalima Johnson Greene	3/4/5	Chief Financial Officer	0.15%	500,350	$705,493	—	04 Mar 2026	3/4/5
MORGAN STANLEY	13F	Company	0.14%	463,454	$625,663	—	31 Dec 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.13%	426,293	$575,496	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.11%	352,127	$475,371	—	31 Dec 2025	13F
OMERS ADMINISTRATION Corp	13F	Company	0.1%	331,300	$447,255	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.08%	267,500	$361,125	—	31 Dec 2025	13F
Procyon Advisors, LLC	13F	Company	0.07%	224,100	$302,535	—	31 Dec 2025	13F
Squarepoint Ops LLC	13F	Company	0.07%	218,392	$294,829	—	31 Dec 2025	13F
Mitsubishi UFJ Asset Management Co., Ltd.	13F	Company	0.06%	209,214	$288,715	—	31 Dec 2025	13F
Arun Upadhyay	3/4/5	Chief Scientific Officer, Head of Research, Development and Medical	— mixed-class rows	1,037,191 mixed-class rows	$273,893	—	02 Jan 2025	3/4/5
Ramesh Ramachandran	3/4/5	Chief Accounting Officer	— mixed-class rows	520,050 mixed-class rows	$271,830	—	02 Jan 2026	3/4/5
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.06%	192,900	$260,415	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.05%	171,723	$231,826	—	31 Dec 2025	13F
Lighthouse Investment Partners, LLC	13F	Company	0.05%	171,000	$230,850	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.05%	157,500	$212,625	—	31 Dec 2025	13F
FMR LLC	13F	Company	0.05%	150,836	$203,629	—	31 Dec 2025	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.04%	145,435	$196,337	—	31 Dec 2025	13F
Quadrature Capital Ltd	13F	Company	0.04%	143,929	$194,304	—	31 Dec 2025	13F
NewEdge Advisors, LLC	13F	Company	0.04%	135,460	$182,871	—	31 Dec 2025	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.04%	134,911	$182,130	—	31 Dec 2025	13F
GROUP ONE TRADING LLC	13F	Company	0.04%	118,307	$159,714	—	31 Dec 2025	13F
ExodusPoint Capital Management, LP	13F	Company	0.04%	114,979	$155,222	—	31 Dec 2025	13F
Jain Global LLC	13F	Company	0.03%	114,690	$154,832	—	31 Dec 2025	13F
Jefferies Financial Group Inc.	13F	Company	0.03%	101,935	$137,612	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	0.03%	101,878	$137,535	—	31 Dec 2025	13F
Lanham O'Dell & Company, Inc.	13F	Company	0.03%	100,000	$135,000	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	98,672	$133,207	—	31 Dec 2025	13F
Caitong International Asset Management Co., Ltd	13F	Company	0.03%	82,317	$111,128	—	31 Dec 2025	13F
Quan Anh Vu	3/4/5	CFO/CBO	— class O/S missing	165,934	$108,355	—	06 Mar 2023	3/4/5

Recent Insider Transactions by Companies or Individuals for Ocugen, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Junge Zhang	OCGN	Common Stock	Options Exercise	16.7%	194,134	1,359,316	01 Apr 2026	Direct
Junge Zhang	OCGN	Option (right to buy)	Options Exercise	-100%	-194,134	0	01 Apr 2026	Direct
Shankar Musunuri	OCGN	Common Stock	Award	170.4%	3,123,201	4,955,924	02 Jan 2026	Direct
Shankar Musunuri	OCGN	Option (Right to Buy)	Award		3,123,201	3,123,201	02 Jan 2026	Direct
Ramesh Ramachandran	OCGN	Common Stock	Award	11516.7%	207,300	209,100	02 Jan 2026	Direct
Ramesh Ramachandran	OCGN	Option (Right to Buy)	Award		310,950	310,950	02 Jan 2026	Direct
Satishchandran Chandrasekhar	OCGN	Option (Right to Buy)	Award		151,316	151,316	05 Jun 2025	Direct
Blaise Coleman	OCGN	Option (Right to Buy)	Award		151,316	151,316	05 Jun 2025	Direct
Kirsten Castillo	OCGN	Option (Right to Buy)	Award		151,316	151,316	05 Jun 2025	Direct
Uday Kompella	OCGN	Option (Right to Buy)	Award		151,316	151,316	05 Jun 2025	Direct
Junge Zhang	OCGN	Option (Right to Buy)	Award		151,316	151,316	05 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.